Work Group Co-Chairs
John J V McMurray, MD, FRCP, FESC BHF Glasgow Cardiovascular Research Centre Glasgow, United Kingdom
Patrick S Parfrey, MD, FRCPC, FRSC Memorial University Medical School St John's, Canada
Work Group
John W Adamson, MD University of California at San Diego San Diego, CA, USA
Pedro Aljama, MD, PhD Hospital Universitario Reina Sofía Córdoba, Spain
Jeffrey S Berns, MD The Perelman School of Medicine at the University of Pennsylvania Philadelphia, PA, USA
Julia Bohlius, MD, MScPH University of Bern Bern, Switzerland
Tilman B Drüeke, MD, FRCP Université de Picardie Jules Verne Amiens, France
Fredric O Finkelstein, MD Yale University New Haven, CT, USA
Steven Fishbane, MD North Shore-LIJ Health System Manhasset, NY, USA
Tomas Ganz, PhD, MD David Geffen School of Medicine at UCLA Los Angeles, CA, USA
Iain C Macdougall, BSc, MD, FRCP King's College Hospital London, United Kingdom
Ruth A McDonald, MD Seattle Children's Hospital Seattle, WA, USA
Lawrence P McMahon, MBBS, MD Monash University Box Hill, Australia
Gregorio T Obrador, MD, MPH Universidad Panamericana School of Medicine Mexico City, Mexico
Giovanni FM Strippoli, MD, PhD, MPH Consorzio Mario Negri Sud Chieti, Italy
Günter Weiss, MD Medical University of Innsbruck Innsbruck, Austria
Andrzej Wie?cek, MD, PhD, FRCP Silesian University School of Medicine Katowice, Poland
Evidence Review Team
Tufts Center for Kidney Disease Guideline Development and Implementation
Tufts Medical Center, Boston, MA, USA:
Ethan M Balk, MD, MPH; Project Director; Program Director, Evidence-based Medicine
Ashish Upadhyay, MD, Assistant Project Director
Dana C Miskulin, MD, MS, Staff Nephrologist
Amy Earley, BS, Project Coordinator
Shana Haynes, MS, DHSc, Research Assistant
Jenny Lamont, MS, Project Manager
In addition, support and supervision were provided by:
Katrin Uhlig, MD, MS; Director, Guideline Development